Effectiveness of maintenance treatments for nonsmall cell lung cancer

JOURNAL ARTICLE published July 2011 in Lung Cancer: Targets and Therapy

Authors: Katharine Price

Single nucleotide polymorphisms as susceptibility, prognostic, and therapeutic markers of nonsmall cell lung cancer

JOURNAL ARTICLE published December 2011 in Lung Cancer: Targets and Therapy

Authors: Shanbeh Zienolddiny | Vidar Skaug

Drug resistance in lung cancer

JOURNAL ARTICLE published May 2010 in Lung Cancer: Targets and Therapy

Authors: Rajagopal Ramesh

Robotic stereotactic body radiation therapy for elderly medically inoperable early-stage non-small cell lung cancer

JOURNAL ARTICLE published August 2013 in Lung Cancer: Targets and Therapy

Authors: Sana Karam | David Duhamel

Amifostine- and chemoradiotherapy-related esophagitis in small cell lung cancer: a single institutional series and literature update

JOURNAL ARTICLE published September 2018 in Lung Cancer: Targets and Therapy

Authors: Ariel Pollock | Lowell Shinn | Richard Anderson | Sarah Butler | Jondavid Pollock

Oligometastatic non-small-cell lung cancer: current treatment strategies

JOURNAL ARTICLE published November 2016 in Lung Cancer: Targets and Therapy

Authors: Patrick J Richard | Ramesh Rengan

Astragalus-containing Chinese herbal combinations for advanced non-small-cell lung cancer: a meta-analysis of 65 clinical trials enrolling 4751 patients

JOURNAL ARTICLE published July 2010 in Lung Cancer: Targets and Therapy

Targeted treatment of mutated EGFR-expressing non-small-cell lung cancer: focus on erlotinib with companion diagnostics

JOURNAL ARTICLE published November 2014 in Lung Cancer: Targets and Therapy

Authors: Niki Karachaliou | Rafael Rosell

Refining the treatment of advanced nonsmall cell lung cancer

JOURNAL ARTICLE published May 2010 in Lung Cancer: Targets and Therapy

Authors: Toni Wozniak

Novel Therapies for Metastatic Non-Small Cell Lung Cancer with MET Exon 14 Alterations: A Spotlight on Capmatinib

JOURNAL ARTICLE published March 2021 in Lung Cancer: Targets and Therapy

Authors: Aaron Tan | Tracy J Loh | Xue Lin Kwang | Gek San Tan | Kiat Hon Lim | Daniel SW Tan

<p>Patients with NSCLCs Harboring Internal Inversions or Deletion Rearrangements of the <em>ALK</em> Gene Have Durable Responses to ALK Kinase Inhibitors</p>

JOURNAL ARTICLE published April 2020 in Lung Cancer: Targets and Therapy

Authors: Alexa B Schrock | Russell Madison | Mark Rosenzweig | Justin M Allen | Rachel L Erlich | Siao-Yi Wang | Tarek Chidiac | Vodur Suresh Reddy | Jonathan W Riess | Ahmet Ersin Yassa | Abdur Shakir | Vincent A Miller | Brian M Alexander | Jeffrey Venstrom | Kimberly McGregor | Siraj M Ali

A pilot study of zoledronic acid in the treatment of patients with advanced malignant pleural mesothelioma

JOURNAL ARTICLE published June 2017 in Lung Cancer: Targets and Therapy

Authors: Muhammad Jamil | Mary Jerome | Debi Miley | Katri Selander | Francisco Robert

Managing Acquired Resistance to Third-Generation EGFR Tyrosine Kinase Inhibitors Through Co-Targeting MEK/ERK Signaling

JOURNAL ARTICLE published February 2021 in Lung Cancer: Targets and Therapy

Authors: Danlei Yu | Wen Zhao | Karin A Vallega | Shi-Yong Sun

<p>Clinical Outcomes of Proton Beam Therapy for Ground-Glass Opacity-Type Lung Cancer</p>

JOURNAL ARTICLE published October 2020 in Lung Cancer: Targets and Therapy

Authors: Ichiro Nagata | Takashi Ogino | Takeshi Arimura | Takashi Yoshiura

<p>A retrospective study evaluating the pretreatment tumor volume (PTV) in non-small cell lung cancer (NSCLC) as a predictor of response to program death-1 (PD-1) inhibitors</p>

JOURNAL ARTICLE published September 2019 in Lung Cancer: Targets and Therapy

Authors: Misako Nagasaka | Nadine Abdallah | Marcus Crosby | Nithin Thummala | Dhaval Patel | Antoinette J Wozniak | Shirish Gadgeel | Judith Abrams | Ammar Sukari

Recognizing Prognostic and Predictive Biomarkers in the Treatment of Non-Small Cell Lung Cancer (NSCLC) with Immune Checkpoint Inhibitors (ICIs)

JOURNAL ARTICLE published March 2021 in Lung Cancer: Targets and Therapy

Authors: Nicholas Giustini | Lyudmila Bazhenova

MARIPOSA: Can Amivantamab and Lazertinib Replace Osimertinib in the Front-Line Setting?

JOURNAL ARTICLE published April 2024 in Lung Cancer: Targets and Therapy

Authors: Danielle Brazel | Misako Nagasaka

<p>Systematic review of sequencing of ALK inhibitors in <em>ALK</em>-positive non-small-cell lung cancer</p>

JOURNAL ARTICLE published February 2019 in Lung Cancer: Targets and Therapy

Authors: Stephanie M. Barrows | Kelly Wright | Catherine Copley-Merriman | James A. Kaye | Marc Chioda | Robin Wiltshire | Knut Martin Torgersen | Elizabeth T. Masters

An Update on Emerging Therapeutic Options for Malignant Pleural Mesothelioma

JOURNAL ARTICLE published March 2022 in Lung Cancer: Targets and Therapy

Authors: Alexander Davis | Helen Ke | Steven Kao | Nick Pavlakis

miRNA-21 as a novel therapeutic target in lung cancer

JOURNAL ARTICLE published March 2016 in Lung Cancer: Targets and Therapy

Authors: Evi Lianidou | Athina Markou | Martha Zavridou